Kidney 2 Flashcards
What is the leading cause of CKD?
Diabetes
What are many CKD guidelines nes based on?
Opinion or preference of doctor due to limited evidence from lack of RCTs
What is CKD
Progressive loss of kidney function occurring over several months to years
How is CKD characterized?
By gradual replacement of normal kidney architecture with fibrosis
What are the two main causes of CKD?
Diabetes and hypertension
Definition of CKD by kidney function or kidney structure
GFR </= 60mL/min/1.73m2 for 3 months or more, with or without kidney damage OR
Kidney damage for >/= 3 months, with or without decreased GFR, as evidenced by pathological abnormalities, abnormalities in blood or urine, or as seen by renal imaging
What are the markers of kidney damage?
Albuminuria (ACR >/= 3mg/mmol)
Urine sediment abnormalities
Abnormalities detected by histology (from biopsy)
Structural abnormalities detected by imaging
History of kidney transplantation
What are the new “rethought” GFR thresholds for CKD?
<40yrs = < 75ml/min
40-65yrs = <60ml/min
>65yrs = <45ml/min (because we see a decline with age and it doesn’t always mean its CKD)
What are the stages of CKD with their related GFR?
G1 = >/= 90ml/min
G2 = 60-89ml/min
G3a = 45-59ml/min
G3b = 30-44ml/min
G4 = 15-29ml/min
G5 = <15ml/min
What are the stages of CKD by albuminuria category(ACR)?
A1 = <3mg/mmol
A2 = 3-30mg/mmol
A3 = >30mg/mmol
To determine the GFR category, what equation would you use to estimate GFR?
CKD-EPI
What is the clinical presentation of CKD?
Often asymptomatic which is why screening is important
- low energy, fatigue, confusion
- foaming, tea-colored, blood or cloudy urine
- edema
- SOB
- pruritis
What are the goals for overall care in CKD?
Delay progression of CKD
CV risk reduction
Treat complications of CKD
Renal replacement therapies (RRT)
What type of CKDs may undergo remission?
Autoimmune
What is associated with seeing a faster decline in GFR?
Lower GFR and greater albuminuria
Which CKD etiologies of CKD tend to progress more quickly?
Diabetic nephropathy
Glomerular diseases
Polycystic kidney disease
Kidney disease in transplant recipients
Which CKD etiologies tend to progress more slowly?
Hypertensive kidney disease
Tubulointerstitial diseases
What factors are associated with faster progression of CKD?
African-American race
Male
Advanced age
Family history
-
Uncontrolled HTN
Poor BG control
Proteinuria
Smoking
Obesity
What are the interventions to delay progression of CKD?
BP control
RAAS blockade - ACEi/ARB or non-steroidal MRAs
BG control in diabetes - SGLT2i and GLP-1 agonists
Smoking cessation
Avoidance of nephrotoxins
What is the difference in decline of GFR between controlled vs. Uncontrolled HTN?
Controlled BP <130/80 = GFR declines by 1-2ml/min/year
Uncontrolled BP = GFR declines by 12ml/min/year
What are the BP targets as per the HTN guidelines?
<130/80 for diabetic CKD
SBP <110 for adults with polycystic kidney disease
SBP <120 for “high risk” patients
SBP <140 for all other patients
What are the BP targets based on the KDIGO HTN guidelines?
SBP <120 for patients with high BP and CKD(not on dialysis), when tolerated
SBP <130/80 for kidney transplant recipients
Which of the following criteria were excluded from the SPRINT trial?
A. eGFR 20-59ml/min
B. Proteinuria <1g/d
C. Framingham risk score >/= 15%
D. Diabetes mellitus
C. Clinical CVD
D. Diabetes mellitus
What are the clinical indications for SBP <120?
AARF* (high risk patients)
Age > 75
Atherosclerosis (CVD disease)
Renal (CKD)
Framingham risk score >15%
What are the cautions and CI for SBP <120?
HF or recent MI
Diabetes mellitus
Previous stroke
eGFR < 20ml/min (includes dialysis and transplant)
*Standing SBP < 110
*Inability to measure SBP accurately
*Known secondary cause of HTN
What was the result of the SPRINT trial?
SBP <120 did not slow CKD progression (perhaps worsening, no impact on ESRD)
What is the lifestyle recommendation for BP control from HTN Canada?
Salt restriction: reduce sodium intake towards 2000mg (5g of salt) per day
Exercise: 30-60 minutes of moderate intensity 4-7 days/week, in addition to the routine acts of daily living
Weight reduction: in overweight/obese patients
Limited alcohol consumption: 1-2 drinks/day
How many BP drugs are often required for BP control as CKD progresses?
3-4
What are the 1st line BP control drugs per KDIGO?
ACEi/ARB
Diuretics
Long-acting CCBs
What is the first line treatment in CKD for HTN if a patient has proteinuria?
ACEi/ARB
Diabetic - ACR >3mg/mmol
Non-diabetic - ACR >30mg/mmol
What are ACEi/ARB role in therapy for CKD?
Reduce BP and glomerular capillary pressure
Reduce proteinuria more than any other antihypertensive
Improvement of kidney outcomes and CV outcomes
CI of ACEi/ARB
Bilateral renal artery stenosis
Angioedema
Pregnancy
Precautions with ACEi/ARB
Intravascular fluid depletion
eGFR <30ml/min
Hypotension (if BP <110/70)
Hyperkalemia (K+ >5.5mmol/L)
What are the monitoring parameters for ACEi/ARB
*2-4 weeks following initiation, or any dose increase
- SCr (dont want an increase >30% from baseline)
- K+ (if high restriction dietary K+, add diuretic)
- BP
- urinary albumin: creatinine ratio (ACR)
Dosing for ACEi/ARB
Reduction in albuminuria is dose-dependent
Start at low dose and titrate to maximum tolerated dose(or highest approved dose)
What are the steroidal (non-selective) MRAs used for HTN in CKD?
Spironolactone**
Eplerenone
What are the non-steroidal (selective) MRAs used for HTN in CKD?
Finerenone - reduction in albuminuria, while having less side effects
When should we use non-steroidal MRAs with proven kidney or CV benefit?
T2DM, eGFR >/=25mL/min, Normal K+ levels, and Albuminuria (ACR >/= 3) despite maximum tolerated dose of a RAASi